PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportslung neoplasms
MeSH D008175 - lung neoplasms
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D012142:Respiratory tract neoplasms
0 Companies
0 Drugs
Success rate
D008171:Lung diseases
3 Companies
2 Drugs
$
Success rate
D008175: 
Lung neoplasms
65 Companies
28 Drugs
$
Success rate
D000086002:Malignant mesothelioma
1 Company
1 Drug
$
Success rate
D001984:Bronchial neoplasms
0 Companies
0 Drugs
Success rate
D010178:Pancoast syndrome
0 Companies
0 Drugs
Success rate
D047868:Pulmonary sclerosing hemangioma
0 Companies
0 Drugs
Success rate
D055613:Multiple pulmonary nodules
0 Companies
0 Drugs
Success rate
D002283:Bronchogenic carcinoma
0 Companies
0 Drugs
Success rate
D000077192:Adenocarcinoma of lung
0 Companies
0 Drugs
Success rate
D018202:Pulmonary blastoma
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaCarboplatin Carboplatin  2005-09-21   
Doxorubicin Doxorubicin  1995-07-28   
Etoposide Etoposide  1994-02-10   
Ifosfamide, Mesna Ifosfamide/mesna  2002-02-26   
Doxorubicin Myocet (previously Myocet)  2000-07-13   
Cyclophosphamide Neosar  1993-04-29   
Etoposide Toposar  1995-02-27   
Cisplatin Cisplatin  2000-05-16   
Novast LaboratoriesCarboplatin Carboplatin  2017-04-26   
Dr Reddys LaboratoriesCyclophosphamide Cyclophosphamide 2036-02-15 2020-07-30   
Doxorubicin Doxorubicin  2017-05-15   
MylanCarboplatin Carboplatin  2007-04-24   
Doxorubicin, Doxorubicin hydrochloride Doxorubicin  2011-10-28   
Etoposide Etoposide  2001-09-19   
Cisplatin Cisplatin  2012-04-18   
Methotrexate Methotrexate  1992-05-15   
NATCO PharmaCarboplatin Carboplatin  2012-05-29   
Rising PharmaceuticalsIfosfamide Ifosfamide  2012-11-26   
Methotrexate Methotrexate  2012-03-29   
CiplaCarboplatin Carboplatin  2006-01-27   
Cyclophosphamide Cyclophosphamide  2019-01-18   
SandozCarboplatin Carboplatin  2005-03-18   
Folic acid, Dexpanthenol, Ascorbic acid, Cyanocobalamin, Vitamin a, Alpha-tocopherol, Biotin, Cholecalciferol, Niacinamide, Pyridoxine, Riboflavin, Thiamine, Tocopherol Infuvite  2000-05-18   
Cyclophosphamide Cyclophosphamide  2023-09-12   
Methotrexate Methotrexate  2009-03-31   
OrganonAlendronic acid, Cholecalciferol Fosamax D  2005-04-07   
Alendronic acid, Cholecalciferol Adrovance  2007-01-04   
Alendronic acid, Cholecalciferol Fosavance  2005-08-24   
Alendronic acid, Cholecalciferol Vantavo (previously Alendronate colecalciferol, MSD)  2009-10-16   
PfizerDoxorubicin Adriamycin  1991-01-30   
Doxorubicin Doxorubicin  1982-01-01   
1
2
3
4
5
6
7
>
Clinical Trials
Historical Success Rate
Phase 1
76%
159/210
Phase 2
36%
109/300
Phase 3
30%
47/155
Approved: 15Overall Success rate: 8%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Carboplatin,
Cisplatin,
Cyclophosphamide,
Doxorubicin,
Doxorubicin hydrochloride,
Etoposide,
Etoposide phosphate
Dr Reddys Laboratories
Doxorubicin,
Doxorubicin hydrochloride
Mylan
Carboplatin
Sandoz
Carboplatin,
Lenograstim,
Molgramostim
Organon
Alendronic acid,
Cholecalciferol
Pfizer
Doxorubicin,
Doxorubicin hydrochloride,
Docusate,
Sitravatinib,
Sasanlimab,
Gilvetmab,
Figitumumab,
Edrecolomab,
Agatolimod,
Tacedinaline,
Prinomastat,
Doconexent,
Ceralasertib,
Docusate sodium,
Bevifimod,
CANERTINIB,
COFETUZUMAB PELIDOTIN,
MAVELERTINIB,
Nepidermin,
PELITREXOL,
Polyglycolic acid,
Sugemalimab,
Telbermin,
VISTUSERTIB,
Globulin, immune,
Ag013736,
Lactams,
Mk3475,
Pf03512676,
Dacomitnib,
Pd0332991,
Folinoral,
Histone-arginine methyltransferase carm1,
Curcumin,
Gemcis,
Surlorian,
Docetaxol,
Hidroxicloroquina,
Taxane,
Isoxaflutole,
Pf00299804,
Pf804
Eli Lilly
Vinblastine,
Benzocaine,
Pegilodecakin,
Lenograstim,
Glutamic acid,
Enzastaurin,
Edrecolomab,
Aprinocarsen,
Calcium dobesilate,
Doconexent,
Methylcobalamin,
Aspartame,
Bevifimod,
CIXUTUMUMAB,
MERESTINIB,
Nepidermin,
Polyglycolic acid,
PREXASERTIB,
SAMOTOLISIB,
Telbermin,
Vilobelimab,
Retinol,
D-glutamate,
Fludeoxyglucose f-18,
Globulin, immune,
Endocrine,
Mk3475,
Folinoral,
Pemcarbo,
Histone-arginine methyltransferase carm1,
Gemcis,
AK-01,
Olomorasib,
Docetaxol,
Taxane
1
2
3
4
5
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use